Metabolic and Bariatric Surgery versus Incretin-Based Therapy in Adults Aged 65 and Older with Type 2 Diabetes: A Nationwide Comparative Analysis of Weight Loss and Cardiometabolic Outcomes
- 17 October 2026
- journal article
- Published by Elsevier in Surgery for Obesity and Related Diseases
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Long‐Term Mortality and Cardiorenal Outcomes After Metabolic and Bariatric Surgery in Patients With Type 2 Diabetes and Obesity: A Retrospective Cohort StudyWorld Journal of Surgery, 2025
- Comparative Efficacy of Metabolic/Bariatric Surgery Versus GLP ‐1 Receptor Agonists: A Network Meta‐Analysis of Randomized Controlled TrialsObesity, 2025
- Primary Metabolic and Bariatric Surgery in Persons Aged over 65 Years. GRADE-based International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Position StatementObesity Surgery, 2025
- GLP-1 RAs and Cardiovascular and Kidney Outcomes by Body Mass Index in Type 2 DiabetesJAMA Network Open, 2025
- Efficacy of GLP-1 receptor agonists among older adults: a meta-analysis of cardio-kidney outcome trialsArchives of Gerontology and Geriatrics, 2025
- Changes in Adult Obesity Trends in the USJAMA Health Forum, 2024
- A 5-year characterization of trends and outcomes in elderly patients undergoing elective bariatric surgerySurgical Endoscopy, 2023
- Age, sex, race, BMI, and duration of diabetes differences in cardiovascular outcomes with glucose lowering drugs in type 2 diabetes: A systematic review and meta-analysiseClinicalMedicine, 2022
- Overlap WeightingJAMA, 2020
- Association Between Adiposity in Midlife and Older Age and Risk of Diabetes in Older AdultsJAMA, 2010